Literature DB >> 8506588

Clinical prognostic factors in transitional cell cancer of the bladder.

P K Lipponen1, M Eskelinen, K Jauhiainen, R Terho, E Harju.   

Abstract

A cohort of 537 patients with transitional cell cancer of the bladder (TCC) were followed up for a mean of 9 years and the clinicopathological data were related to prognosis. The T category (p < 0.0001), N category (p < 0.0001) and M category (p < 0.0001) were the most important clinical prognostic factors, followed by the age of the patient (p < 0.0001). Of the histological variables the WHO grade (p < 0.0001), papillary status (p < 0.0001) and the presence of R3-4 cells in voided urine (p = 0.0061) predicted unfavorable prognosis. In Ta-T1 tumors the WHO grade (p < 0.0001), papillary status (p < 0.0001) and the age of the patient (p < 0.0001) had a prognostic value in univariate analysis. In Cox's analysis independent predictors of survival were the T category (p < 0.0001), WHO grade (p < 0.0001), patient age (p < 0.0001), papillary status (p = 0.012) and the presence of symptoms before diagnosis (p = 0.033). In superficial tumors the WHO grade (p < 0.0001) and patient age (p < 0.0001) were independent predictors of survival.

Entities:  

Mesh:

Year:  1993        PMID: 8506588     DOI: 10.1159/000282482

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.

Authors:  Alan R Schned; Angeline S Andrew; Carmen J Marsit; Karl T Kelsey; Michael S Zens; Margaret R Karagas
Journal:  Scand J Urol Nephrol       Date:  2008

2.  Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?

Authors:  Alaa Mokhtar; Mohamed Matar Al; Waleed Mohamad Al; Khalid Al Othman; Said A Kattan; Mohammed Faihan Al
Journal:  Ann Saudi Med       Date:  2017 May-Jun       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.